Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
1 other identifier
interventional
20
1 country
1
Brief Summary
This pilot study evaluates the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Preliminary efficacy of the HIIT intervention for improved cardiorespiratory fitness, body composition, physical function, autonomic response to exercise, peripheral neuropathy, biological aging markers, and physical activity will also be evaluated. Primary Objective: To determine the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Feasibility will be assessed by:
- Participation Rate: Number of eligible survivors approached who enroll.
- Completion Rate: Number of scheduled HIIT sessions attended and number of enrolled participants who complete post-intervention testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2025
CompletedFirst Posted
Study publicly available on registry
October 29, 2025
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
April 23, 2026
April 1, 2026
1.8 years
October 27, 2025
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participation rate (percent of eligible participants approached who enroll)
Descriptive statistics will be reported
Trial completion (12 weeks)
Completion rate (percentage of scheduled HIIT sessions attended and percentage of post-intervention testing sessions completed)
Descriptive statistics will be reported
Trial completion (12 weeks)
Other Outcomes (15)
Cardiorespiratory fitness (VO2peak, ml/kg/min)
baseline at study entry, 12 weeks
Ewing battery score of autonomic function (0 to 5 points)
baseline at study entry, 12 weeks
Body mass index (weight and height will be combined to report body mass index in kg/m2)
baseline at study entry, 12 weeks
- +12 more other outcomes
Study Arms (1)
HIIT Intervention Group
EXPERIMENTALParticipants will complete a 12-week HIIT program with three 25-minute sessions per week. Each session includes warm-up, five cycles of high-intensity intervals (80-95% peak HR) and recovery periods (50-60% peak HR), and cool-down.
Interventions
Participants will complete a 12-week HIIT program with three 25-minute sessions per week. Each session includes warm-up, five cycles of high-intensity intervals (80-95% peak HR) and recovery periods (50-60% peak HR), and cool-down.
Eligibility Criteria
You may qualify if:
- Participant has been diagnosed with Hodgkin lymphoma between the ages of 10 to 25 years.
- Participant is between the ages of \>10 and \<25 years old the time of enrollment.
- Participant has completed treatment (end of chemotherapy for those not receiving radiation therapy or end of radiation therapy) for Hodgkin lymphoma within 24 months prior to enrollment and recovered from any acute treatment-related adverse events.
- Participant has been medically cleared to participate in physical activity.
- Participant verbalizes understanding of directions for use of the web-based platform on the study provided iPad and heart rate monitor.
You may not qualify if:
- Participant has evidence of relapsed disease.
- Participant has a diagnosis of acute heart failure.
- Participant reports currently participating in HIIT training or \>420 minutes per week of moderate to vigorous physical activity.
- Female participant who is currently pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Berkman, MD
St. Jude Children's Research Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2025
First Posted
October 29, 2025
Study Start
April 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2029
Last Updated
April 23, 2026
Record last verified: 2026-04